Jianming Zhang

Molecular Biology · Nature Reviews. Cancer · 2008–2014

A researcher in the Science corpus: 5 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom Jianming Zhang trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Yi Liu
  2. Nathanael S. Gray
  3. Zachary A. Knight
  4. Yardena Samuels

Who trusts Jianming Zhang overall

  1. R. Roskoski
  2. G. Williams

Papers from Jianming Zhang's perspective

Ordered by how strongly the researchers Jianming Zhang trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL. (Cell)
  2. The PIK3CA gene is mutated with high frequency in human breast cancers (Cancer Biology & Therapy)
  3. BRAF mutation predicts sensitivity to MEK inhibition (Nature)
  4. A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
  5. Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL. (New England Journal of Medicine)
  6. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. (New England Journal of Medicine)
  7. Accurate Whole Human Genome Sequencing using Reversible Terminator Chemistry (Nature)
  8. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. (New England Journal of Medicine)
  9. Klf4 reverts developmentally programmed restriction of ground state pluripotency (Development)
  10. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity (Proceedings of the National Academy of Sciences of the United States of America)

Their papers